Beauty Health (SKIN)
Beauty Health Statistics
Share Statistics
Beauty Health has 126.01M shares outstanding. The number of shares has increased by 1.3% in one year.
| 126.01M |
| 1.3% |
| 0.9% |
| 59.04% |
| 73.89M |
| 5,610 |
| 0.71% |
Short Selling Information
The latest short interest is 8.37M, so 6.64% of the outstanding shares have been sold short.
| 8.37M |
| 6.64% |
| 14.83% |
| 13.55 |
Valuation Ratios
The PE ratio is -6.77 and the forward PE ratio is -10.96. Beauty Health's PEG ratio is 0.07.
| -6.77 |
| -10.96 |
| 0.59 |
| 0.4 |
| 3.8 |
| 21.08 |
| 0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Beauty Health.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 7, with a Debt / Equity ratio of 10.97.
| 7 |
| 5.99 |
| 10.97 |
| 54.95 |
| 60.83 |
| -6.51 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $434,712.61 |
| $-37,838.75 |
| 769 |
| 0.49 |
| 2.2 |
Taxes
| -452K |
| 1.53% |
Stock Price Statistics
The stock price has increased by -15.93% in the last 52 weeks. The beta is 1.18, so Beauty Health's price volatility has been higher than the market average.
| 1.18 |
| -15.93% |
| 1.34 |
| 1.49 |
| 50.2 |
| 792,495 |
Income Statement
In the last 12 months, Beauty Health had revenue of 334.29M and earned -29.1M in profits. Earnings per share was -0.05.
| 334.29M |
| 182.3M |
| -67.77M |
| -29.1M |
| 10.34M |
| -19.14M |
| -0.05 |
Balance Sheet
The company has 370.06M in cash and 568.16M in debt, giving a net cash position of -198.09M.
| 370.06M |
| 568.16M |
| -198.09M |
| -507.96M |
| 673.82M |
| 406.57M |
Cash Flow
In the last 12 months, operating cash flow was 16.13M and capital expenditures -6.79M, giving a free cash flow of 9.34M.
| 16.13M |
| -6.79M |
| 9.34M |
| 0.08 |
Margins
Gross margin is 54.53%, with operating and profit margins of -20.27% and -8.7%.
| 54.53% |
| -20.27% |
| -8.84% |
| -8.7% |
| 3.09% |
| -20.27% |
| 2.79% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for SKIN is $1.25, which is -18.3% lower than the current price. The consensus rating is "Hold".
| $1.25 |
| -18.3% |
| Hold |
| 3 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 0.18 |
| 6 |